Laporan Laba Rugi (TTM)
Laporan Laba Rugi Indo-Bangla Pharmaceuticals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 07-01 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 07-01 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 862 | 843 | 788 | 782 | 731 | 654 | 619 | 485 | 447 | 416 | 375 | 374 | 338 | 296 | 212 | 177 | 119 | 88 | 91 |
| Change (%) | -2.23 | -6.51 | -0.70 | -6.61 | -10.50 | -5.30 | -21.72 | -7.69 | -7.08 | -9.85 | -0.08 | -9.66 | -12.53 | -28.48 | -16.53 | -32.59 | -25.83 | 3.15 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 523 | 515 | 506 | 469 | 437 | 403 | 381 | 338 | 327 | 311 | 278 | 278 | 265 | 242 | 182 | 157 | 109 | 82 | 87 |
| Change (%) | -1.37 | -1.90 | -7.18 | -6.99 | -7.78 | -5.29 | -11.41 | -3.16 | -5.05 | -10.56 | 0.06 | -4.48 | -8.86 | -24.76 | -13.87 | -30.31 | -24.80 | 5.82 | |
| % of Revenue | 60.64 | 61.17 | 64.19 | 59.99 | 59.75 | 61.57 | 61.57 | 69.69 | 73.10 | 74.70 | 74.11 | 74.21 | 78.47 | 81.77 | 86.02 | 88.76 | 91.77 | 93.05 | 95.45 |
| Gross Operating Profit | 339 | 327 | 282 | 313 | 294 | 251 | 238 | 147 | 120 | 105 | 97 | 97 | 73 | 54 | 30 | 20 | 10 | 6 | 4 |
| Change (%) | -3.56 | -13.78 | 10.93 | -6.04 | -14.54 | -5.32 | -38.25 | -18.10 | -12.59 | -7.76 | -0.49 | -24.58 | -25.94 | -45.17 | -32.88 | -50.60 | -37.37 | -32.56 | |
| % of Revenue | 39.36 | 38.83 | 35.81 | 40.01 | 40.25 | 38.43 | 38.43 | 30.31 | 26.90 | 25.30 | 25.89 | 25.79 | 21.53 | 18.23 | 13.98 | 11.24 | 8.23 | 6.95 | 4.55 |
| SG&A | 135 | 138 | 134 | 140 | 121 | 103 | 92 | 111 | 109 | 124 | 128 | 68 | 65 | 44 | 32 | 44 | 38 | 34 | 34 |
| Change (%) | 2.51 | -2.68 | 3.88 | -13.39 | -15.14 | -10.78 | 21.37 | -2.04 | 14.36 | 2.44 | -46.77 | -4.74 | -31.81 | -27.56 | 36.55 | -12.07 | -10.80 | -0.61 | |
| % of Revenue | 15.63 | 16.39 | 17.07 | 17.85 | 16.55 | 15.70 | 14.79 | 22.93 | 24.33 | 29.94 | 34.03 | 18.13 | 19.11 | 14.90 | 15.09 | 24.69 | 32.20 | 38.73 | 37.32 |
| R&D | |||||||||||||||||||
| Change (%) | |||||||||||||||||||
| % of Revenue | |||||||||||||||||||
| OpEx | 657 | 654 | 640 | 609 | 557 | 505 | 473 | 449 | 436 | 435 | 405 | 346 | 330 | 286 | 214 | 200 | 148 | 116 | 121 |
| Change (%) | -0.58 | -2.07 | -4.86 | -8.46 | -9.38 | -6.40 | -5.06 | -2.88 | -0.20 | -6.84 | -14.68 | -4.53 | -13.35 | -25.19 | -6.34 | -26.34 | -21.16 | 3.93 | |
| % of Revenue | 76.27 | 77.56 | 81.25 | 77.85 | 76.30 | 77.26 | 76.36 | 92.61 | 97.43 | 104.64 | 108.14 | 92.34 | 97.59 | 96.67 | 101.12 | 113.45 | 123.97 | 131.77 | 132.77 |
| Operating Income | 205 | 189 | 148 | 173 | 173 | 149 | 146 | 36 | 11 | -19 | -30 | 29 | 8 | 10 | -2 | -24 | -29 | -28 | -30 |
| Change (%) | -7.56 | -21.89 | 17.36 | -0.11 | -14.12 | -1.55 | -75.54 | -67.94 | -268.15 | 57.99 | -194.08 | -71.52 | 20.57 | -123.97 | 906.27 | 20.12 | -1.68 | 6.38 | |
| % of Revenue | 23.73 | 22.44 | 18.75 | 22.15 | 23.70 | 22.74 | 23.64 | 7.39 | 2.57 | -4.64 | -8.14 | 7.66 | 2.41 | 3.33 | -1.12 | -13.45 | -23.97 | -31.77 | -32.77 |
| Interest Expense | -0 | -1 | -3 | -4 | -5 | -5 | -4 | -5 | -5 | -6 | -7 | -5 | -5 | -5 | -4 | -4 | -4 | -4 | -4 |
| Change (%) | 1,932.91 | 132.81 | 48.79 | 25.02 | -3.36 | -8.54 | 15.82 | 4.03 | 17.40 | 10.38 | -20.50 | -1.15 | -8.47 | -13.14 | 7.10 | -4.52 | 5.25 | 1.14 | |
| % of Revenue | -0.01 | -0.13 | -0.33 | -0.49 | -0.65 | -0.70 | -0.68 | -1.01 | -1.13 | -1.43 | -1.76 | -1.40 | -1.53 | -1.60 | -1.94 | -2.49 | -3.53 | -5.01 | -4.91 |
| Net Income | 150 | 137 | 105 | 135 | 135 | 118 | 117 | 25 | 7 | -22 | -35 | 8 | -10 | -8 | -18 | -41 | -45 | -44 | -46 |
| Change (%) | -8.31 | -23.39 | 28.05 | 0.30 | -12.98 | -0.61 | -78.46 | -72.48 | -419.96 | 56.08 | -124.30 | -224.58 | -23.37 | 125.31 | 126.60 | 9.77 | -1.29 | 3.63 | |
| % of Revenue | 17.38 | 16.30 | 13.36 | 17.22 | 18.50 | 17.98 | 18.88 | 5.19 | 1.55 | -5.33 | -9.23 | 2.24 | -3.10 | -2.71 | -8.55 | -23.20 | -37.78 | -50.27 | -50.51 |
Source: Capital IQ
